Results of new statin trials: Should the low-density lipoprotein cholesterol treatment guidelines be revised? Allison M. J. RossTheodore G. Ganiats OriginalPaper Pages: 11 - 16
Utility of statin therapy using high-sensitivity C-reactive protein as an indicator of coronary heart disease risk Vijay NambiChristie M. Ballantyne OriginalPaper Pages: 22 - 28
Rationale for combination therapy with statin drugs in the treatment of dyslipidemia Benjamin J. Ansell OriginalPaper Pages: 29 - 33
Pleiotropic effects of statins: Moving beyond cholesterol control Paul J. Garcia OriginalPaper Pages: 34 - 39
Inflammation as a mechanism and therapeutic target for in-stent restenosis Douglas E. DrachmanDaniel I. Simon OriginalPaper Pages: 44 - 49
The impact of antidiabetic therapies on cardiovascular disease Brandy PanuntiBiju KunhiramanVivian Fonseca OriginalPaper Pages: 50 - 57
Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis Clifford D. L. FolmesAlexander S. ClanachanGary D. Lopaschuk OriginalPaper Pages: 63 - 70
Antioxidants and atherosclerosis: Emerging drug therapies Jean-Claude Tardif OriginalPaper Pages: 71 - 77